In one paragraphReview in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Anastasia GolovinaTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, Federal Territory "Sirius", 354340 Sochi, Russia.
Fedor AntipinTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, Federal Territory "Sirius", 354340 Sochi, Russia.ORCID 0009-0006-0843-3742 Igor KhalymbadzhaTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, Federal Territory "Sirius", 354340 Sochi, Russia.
Olga TerinaTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, Federal Territory "Sirius", 354340 Sochi, Russia.ORCID 0009-0006-7912-3282 Daniil YakovlevTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, Federal Territory "Sirius", 354340 Sochi, Russia.ORCID 0009-0002-8659-4585 Elena FedinaTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, Federal Territory "Sirius", 354340 Sochi, Russia.ORCID 0009-0004-4218-0406 Roman IvanovTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, Federal Territory "Sirius", 354340 Sochi, Russia.ORCID 0000-0002-9573-4183 Funding
This work was supported by the grant of the state program of the "Sirius" Federal Territory "Scientific and technological development of the "Sirius" Federal Territory" ( Agreement №30-03 date 07.07.2025) This work was supported by the grant of the state program of the "Sirius" Federal Territory "Scientific and technological development of the "Sirius" Federal Territory" ( Agreement №30-03 date 07.07.2025)
6 · The paper itselfAbstract
The escalating global burden of antimicrobial resistance constitutes a public health crisis. The World Health Organization reports that epidemiological models project 10 million deaths attributable to this issue annually by 2050. Among resistant pathogens, metallo-β-lactamase (MBL)-producing organisms represent a clinical challenge, given their consistent association with high rates of morbidity and mortality. This review summarizes effective treatment options against MBL-producing
Indexed as
Anti-Bacterial Agentsbeta-LactamasesDrug Resistance, Multiple, BacterialEnterobacteriaceaeEnterobacteriaceae InfectionsAzabicyclo CompoundsAztreonambeta-Lactamase InhibitorsCefiderocolCeftazidimeDrug CombinationsHumansMicrobial Sensitivity TestsAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsAztreonambeta-Lactamase Inhibitorsbeta-LactamasesCefiderocolCeftazidimeDrug Combinationsaztreonam–avibactamcefiderocolceftazidime–avibactam + aztreonamcolistinEnterobacteralesfosfomycinmetallo-beta-lactamasetigecycline
Identifiers
PMID42353039
PMCPMC13299144
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390